Home / Cancer and immune system / Idelalisib
ATC L01EM01 · Phosphatidylinositol-3-Kinase (Pi3K) Inhibitors · updated 2 Nov 2026
Idelalisib shortage
As of 2 Nov 2026, Idelalisib has a reported shortage in 1 of the 16 countries we track (United States), covering 2 products from 1 company.
Is there an Idelalisib shortage?
Yes. As of 2 Nov 2026, Idelalisib is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Gilead GILD · Nasdaq
Compared with similar medicines
ATC group L01EM · Phosphatidylinositol-3-Kinase (Pi3K) InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Zydelig, Tablet, 100 mg (NDC 61958-1701-1) discontinuation | Gilead Sciences, Inc. | 7 Apr 2026 | not given | Not stated |
| US | Zydelig, Tablet, 150 mg (NDC 61958-1702-1) discontinuation | Gilead Sciences, Inc. | 7 Apr 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Idelalisib shortage?
Yes. As of 2 Nov 2026, Idelalisib is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
When will Idelalisib be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Idelalisib in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Idelalisib shortages?
Gilead.